Zimmer Biomet Holdings(ZBH) modestly calls itself “a global leader in musculoskeletal healthcare.” Last week, it announced it will be slimming down, with plans to spinoff its Spine and Dental businesses in mid-2022. With a market cap of over $32 Billion, Zimmer Biomet is anything but a small company. “As part of the third phase of ZB’s ongoing transformation,… Read More »
DuPont(DD) has been no stranger to spinoffs. Following the 2015 spinoff of Chemours(CC), DuPont merged with Dow Chemical in preparation for a three-way split executed earlier this year, leaving DuPont, Dow Chemical(DOW) and Corteva(CTVA) as independent companies. But there is no rest for the weary. Citigroup analyst P.J. Juvekar believes there is more to come. “We expect DuPont… Read More »
Perhaps readers thought that the DowDupont spinoff was beaten to death and were glad to see the final spinoff date pass. Sorry to disappoint, but there’s still more to say on the subject (and likely will be for some time!). In this week’s Odds and Ends we catch up on some of the recent action: 1. DuPont Gets… Read More »
A recent piece in Barron’s notes that “Sanford Bernstein analyst Jonas Oxgaard recently called the DowDuPont merger and 3-way split the “most complicated action in corporate history.”” It goes on to note, regarding the scale of the transactions: Oxgaard’s claim is difficult to verify, but it doesn’t feel far from the truth. Consider, legacy-Dow and legacy-duPont announced their intention to form the largest… Read More »
It seem like just last month that DowDuPont(DWDP) completed the spinoff of Dow(DOW). As was planned from the moment Dow and DuPont merged just a few short years ago, DowDuPont has one more spinoff to complete before it changes its name back to DuPont(or DuPont de Nemours, Inc., to be precise), and its ticker back to DD. DowDuPont’s… Read More »
A few short hits for a December Friday: By now, everyone has read about the proposed ‘mega merger of equals’ between Dow Chemical (DOW) and DuPont (DD) and the subsequent breakup into three separate companies (agriculture, specialty products and materials). One question worth pondering is how does it actually avoid the tax man? It sure seems like a… Read More »
DuPont (DD) unveiled the future board of directors at its performance chemicals spinoff, Chemour, earlier this week and poor Nelson Peltz didn’t make the cut here either. Surprisingly, the media isn’t covering this board situation in the same manner as last week’s ‘historic’ proxy battle, which witnessed DuPont CEO Ellen Kullman take down Nelson Peltz’s Trian Fund at the ballot box. The… Read More »
There are few companies in America with as long a history as DuPont (DD). Started as a gunpowder mill in Delaware in 1802, the company has been a fixture on the American business landscape for over two centuries. DuPont was a force behind the creation and growth of General Motors (GM) and invented many of the signature materials… Read More »